Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]

Sandeep Mukherjee

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]'. Together they form a unique fingerprint.